Quarterly report [Sections 13 or 15(d)]

Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity

v3.26.1
Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   79,419,028      
Beginning balance at Dec. 31, 2024 $ 221,938 $ 7 $ 407,076 $ 1,753 $ (186,898)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1,611,847      
Issuance of common stock upon exercise of stock options 74   74    
Issuance of common stock upon settlement of restricted stock units (in shares)   2,450,677      
Issuance of common stock upon settlement of restricted stock units 0        
Stock-based compensation - restricted stock 9,566   9,566    
Shares withheld related to net share settlement (in shares)   (1,785,947)      
Shares withheld related to net share settlement (5,457)   (5,457)    
Other comprehensive income 4,215     4,215  
Net loss (7,236)       (7,236)
Ending balance (in shares) at Jun. 30, 2025   81,695,605      
Ending balance at Jun. 30, 2025 223,100 $ 7 411,259 5,968 (194,134)
Beginning balance (in shares) at Mar. 31, 2025   80,973,634      
Beginning balance at Mar. 31, 2025 219,732 $ 7 407,047 3,069 (190,391)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   43,680      
Issuance of common stock upon exercise of stock options 14   14    
Issuance of common stock upon settlement of restricted stock units (in shares)   985,270      
Issuance of common stock upon settlement of restricted stock units 0        
Stock-based compensation - restricted stock 5,349   5,349    
Shares withheld related to net share settlement (in shares)   (306,979)      
Shares withheld related to net share settlement (1,151)   (1,151)    
Other comprehensive income 2,899     2,899  
Net loss (3,743)       (3,743)
Ending balance (in shares) at Jun. 30, 2025   81,695,605      
Ending balance at Jun. 30, 2025 223,100 $ 7 411,259 5,968 (194,134)
Beginning balance (in shares) at Dec. 31, 2025   86,702,183      
Beginning balance at Dec. 31, 2025 $ 279,072 $ 7 424,616 0 (145,551)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 311,960 311,960      
Issuance of common stock upon exercise of stock options $ 55   55    
Issuance of common stock upon settlement of restricted stock units (in shares)   2,340,464      
Issuance of common stock upon settlement of restricted stock units 0   0    
Stock-based compensation - restricted stock 8,741   8,741    
Shares withheld related to net share settlement (in shares)   (954,527)      
Shares withheld related to net share settlement (4,788)   (4,788)    
Issuance of common stock in acquisition 4,267   4,267    
Retirement of common stock (in shares)   (675,334)      
Retirement of common stock 0   0   0
Non-cash capital contribution 333   333    
Other comprehensive income 0        
Net loss (8,362)       (8,362)
Ending balance (in shares) at Jun. 30, 2026   88,466,806      
Ending balance at Jun. 30, 2026 279,318 $ 7 433,224 0 (153,913)
Beginning balance (in shares) at Mar. 31, 2026   86,521,570      
Beginning balance at Mar. 31, 2026 285,731 $ 7 429,121 0 (143,397)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   25,000      
Issuance of common stock upon exercise of stock options 3   3    
Issuance of common stock upon settlement of restricted stock units (in shares)   2,004,366      
Issuance of common stock upon settlement of restricted stock units 0        
Stock-based compensation - restricted stock 3,706   3,706    
Shares withheld related to net share settlement (in shares)   (826,190)      
Shares withheld related to net share settlement (4,206)   (4,206)    
Issuance of common stock in acquisition (in shares)   742,060      
Issuance of common stock in acquisition 4,267   4,267    
Non-cash capital contribution 333   333    
Other comprehensive income 0        
Net loss (10,516)       (10,516)
Ending balance (in shares) at Jun. 30, 2026   88,466,806      
Ending balance at Jun. 30, 2026 $ 279,318 $ 7 $ 433,224 $ 0 $ (153,913)